Macrogenics News

Macrogenics | 8-K: MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data

May 9 17:13 ET

Macrogenics | 8-K: Current report

May 9 16:13 ET

Macrogenics | 10-Q: Quarterly report

May 9 16:08 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Peters Jeffrey Stuart

Apr 8 18:09 ET

Macrogenics | ARS: Annual Report to Security Holders

Apr 8 16:38 ET

Macrogenics | DEF 14A: Definitive information statements

Apr 8 16:34 ET

Macrogenics | DEFA14A: Others

Apr 8 16:34 ET

Macrogenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 4 17:02 ET

Macrogenics | 8-K: Current report

Apr 3 17:30 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Peters Jeffrey Stuart

Mar 8 16:19 ET

Macrogenics | 10-K: Annual report

Mar 7 16:13 ET

Macrogenics | 8-K: Current report

Mar 7 16:06 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Risser Eric Blasius

Mar 6 16:28 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Spitznagel Thomas

Mar 6 16:24 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Karrels James

Mar 6 16:24 ET

Macrogenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 6 16:22 ET

Macrogenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 18:02 ET

Macrogenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 17:53 ET

Macrogenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 17:44 ET

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Officer Peters Jeffrey Stuart

Feb 28 22:50 ET